PSX: ABOT Statistics

Total Valuation

Abbott Laboratories (Pakistan) has a market cap or net worth of PKR 117.48 billion. The enterprise value is 113.67 billion.

Market Cap	117.48B
Enterprise Value	113.67B

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Abbott Laboratories (Pakistan) has 97.90 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	n/a
Shares Outstanding	97.90M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	9.37%
Float	20.69M

Valuation Ratios

The trailing PE ratio is 23.48.

PE Ratio	23.48
Forward PE	n/a
PS Ratio	1.84
PB Ratio	5.24
P/TBV Ratio	5.24
P/FCF Ratio	60.73
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 58.76.

EV / Earnings	22.72
EV / Sales	1.78
EV / EBITDA	13.35
EV / EBIT	16.78
EV / FCF	58.76

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.00.

Current Ratio	1.77
Quick Ratio	0.65
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.03
Interest Coverage	404.61

Financial Efficiency

Return on equity (ROE) is 25.69% and return on invested capital (ROIC) is 21.63%.

Return on Equity (ROE)	25.69%
Return on Assets (ROA)	11.10%
Return on Capital (ROIC)	21.63%
Revenue Per Employee	44.63M
Profits Per Employee	3.50M
Employee Count	1,430
Asset Turnover	1.67
Inventory Turnover	3.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +167.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+167.72%
50-Day Moving Average	1,014.30
200-Day Moving Average	754.23
Relative Strength Index (RSI)	64.92
Average Volume (20 Days)	123,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Abbott Laboratories (Pakistan) had revenue of PKR 63.81 billion and earned 5.00 billion in profits. Earnings per share was 51.10.

Revenue	63.81B
Gross Profit	17.55B
Operating Income	6.77B
Pretax Income	7.66B
Net Income	5.00B
EBITDA	8.43B
EBIT	6.77B
Earnings Per Share (EPS)	51.10

Full Income Statement

Balance Sheet

The company has 3.86 billion in cash and 50.27 million in debt, giving a net cash position of 3.81 billion or 38.90 per share.

Cash & Cash Equivalents	3.86B
Total Debt	50.27M
Net Cash	3.81B
Net Cash Per Share	38.90
Equity (Book Value)	22.43B
Book Value Per Share	229.13
Working Capital	10.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.86 billion and capital expenditures -2.93 billion, giving a free cash flow of 1.93 billion.

Operating Cash Flow	4.86B
Capital Expenditures	-2.93B
Free Cash Flow	1.93B
FCF Per Share	19.76

Full Cash Flow Statement

Margins

Gross margin is 27.50%, with operating and profit margins of 10.62% and 7.84%.

Gross Margin	27.50%
Operating Margin	10.62%
Pretax Margin	12.00%
Profit Margin	7.84%
EBITDA Margin	13.21%
EBIT Margin	10.62%
FCF Margin	3.03%

Dividends & Yields

Abbott Laboratories (Pakistan) does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.04%
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	4.26%
FCF Yield	1.65%

Dividend Details

Stock Splits

The last stock split was on August 9, 2006. It was a forward split with a ratio of 1.20482.

Last Split Date	Aug 9, 2006
Split Type	Forward
Split Ratio	1.20482

Scores

Abbott Laboratories (Pakistan) has an Altman Z-Score of 5.59.

Altman Z-Score	5.59
Piotroski F-Score	n/a